Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1929 1
1946 2
1947 3
1949 2
1950 2
1951 1
1952 2
1953 4
1954 1
1955 7
1956 3
1957 3
1958 1
1959 1
1960 1
1961 1
1962 2
1963 2
1964 1
1965 6
1966 6
1967 4
1968 1
1969 5
1970 6
1971 5
1972 6
1973 2
1974 8
1975 7
1976 8
1977 1
1978 11
1979 4
1980 9
1981 5
1982 15
1983 13
1984 16
1985 18
1986 13
1987 12
1988 12
1989 21
1990 24
1991 26
1992 38
1993 29
1994 27
1995 37
1996 35
1997 37
1998 39
1999 47
2000 40
2001 29
2002 45
2003 50
2004 48
2005 55
2006 52
2007 78
2008 88
2009 85
2010 101
2011 102
2012 124
2013 108
2014 136
2015 131
2016 152
2017 139
2018 158
2019 197
2020 224
2021 254
2022 243
2023 251
2024 235
2025 160

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,490 results

Results by year

Filters applied: . Clear all
Page 1
Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Dairy Farm Worker.
Uyeki TM, Milton S, Abdul Hamid C, Reinoso Webb C, Presley SM, Shetty V, Rollo SN, Martinez DL, Rai S, Gonzales ER, Kniss KL, Jang Y, Frederick JC, De La Cruz JA, Liddell J, Di H, Kirby MK, Barnes JR, Davis CT. Uyeki TM, et al. Among authors: de la cruz ja. N Engl J Med. 2024 Jun 6;390(21):2028-2029. doi: 10.1056/NEJMc2405371. Epub 2024 May 3. N Engl J Med. 2024. PMID: 38700506 No abstract available.
Measurable Residual Disease by Next-Generation Flow Cytometry in Multiple Myeloma.
Paiva B, Puig N, Cedena MT, Rosiñol L, Cordón L, Vidriales MB, Burgos L, Flores-Montero J, Sanoja-Flores L, Lopez-Anglada L, Maldonado R, de la Cruz J, Gutierrez NC, Calasanz MJ, Martin-Ramos ML, Garcia-Sanz R, Martinez-Lopez J, Oriol A, Blanchard MJ, Rios R, Martin J, Martinez-Martinez R, Sureda A, Hernandez MT, de la Rubia J, Krsnik I, Moraleda JM, Palomera L, Bargay J, Van Dongen JJM, Orfao A, Mateos MV, Blade J, San-Miguel JF, Lahuerta JJ; GEM (Grupo Español de Mieloma)/PETHEMA (Programa Para el Estudio de la Terapéutica en Hemopatías Malignas) Cooperative Study Group. Paiva B, et al. Among authors: de la cruz j. J Clin Oncol. 2020 Mar 10;38(8):784-792. doi: 10.1200/JCO.19.01231. Epub 2019 Nov 26. J Clin Oncol. 2020. PMID: 31770060 Free article.
Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results.
Mailankody S, Matous JV, Chhabra S, Liedtke M, Sidana S, Oluwole OO, Malik S, Nath R, Anwer F, Cruz JC, Htut M, Karski EE, Lovelace W, Dillon M, Butz E, Ying W, Balakumaran A, Kumar SK. Mailankody S, et al. Among authors: cruz jc. Nat Med. 2023 Feb;29(2):422-429. doi: 10.1038/s41591-022-02182-7. Epub 2023 Jan 23. Nat Med. 2023. PMID: 36690811 Clinical Trial.
Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study.
O'Shaughnessy J, Sousa S, Cruz J, Fallowfield L, Auvinen P, Pulido C, Cvetanovic A, Wilks S, Ribeiro L, Burotto M, Klingbiel D, Messeri D, Alexandrou A, Trask P, Fredriksson J, Machackova Z, Stamatovic L; PHranceSCa study group. O'Shaughnessy J, et al. Among authors: cruz j. Eur J Cancer. 2021 Jul;152:223-232. doi: 10.1016/j.ejca.2021.03.047. Epub 2021 Jun 16. Eur J Cancer. 2021. PMID: 34147014 Free article. Clinical Trial.
Transmission of a human isolate of clade 2.3.4.4b A(H5N1) virus in ferrets.
Pulit-Penaloza JA, Belser JA, Brock N, Kieran TJ, Sun X, Pappas C, Zeng H, Carney P, Chang J, Bradley-Ferrell B, Stevens J, De La Cruz JA, Hatta Y, Di H, Davis CT, Tumpey TM, Maines TR. Pulit-Penaloza JA, et al. Among authors: de la cruz ja. Nature. 2024 Dec;636(8043):705-710. doi: 10.1038/s41586-024-08246-7. Epub 2024 Oct 28. Nature. 2024. PMID: 39467572 Free PMC article.
Long-term patient-reported outcomes from monarchE: Abemaciclib plus endocrine therapy as adjuvant therapy for HR+, HER2-, node-positive, high-risk, early breast cancer.
Tolaney SM, Guarneri V, Seo JH, Cruz J, Abreu MH, Takahashi M, Barrios C, McIntyre K, Wei R, Munoz M, Antonio BS, Liepa AM, Martin M, Johnston SRD, Kellokumpu-Lehtinen PL, Harbeck N. Tolaney SM, et al. Among authors: cruz j. Eur J Cancer. 2024 Mar;199:113555. doi: 10.1016/j.ejca.2024.113555. Epub 2024 Jan 16. Eur J Cancer. 2024. PMID: 38244363 Free article.
3,490 results